Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole blood RNA-Seq data of Japanese CNO patients and healthy controls

ABSTRACT: whole blood RNA-Seq data of Japanese CNO patients and healthy controls

PROVIDER: PRJNA777562 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16761708_1.fastq.gz	Fastqsanger.gz
	SRR16761708_2.fastq.gz	Fastqsanger.gz
	SRR16761709_1.fastq.gz	Fastqsanger.gz
	SRR16761709_2.fastq.gz	Fastqsanger.gz
	SRR16761710_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 40

Similar Datasets

whole blood RNA-Seq data of Japanese CNO patients and healthy controls

Project description:To explore new aspects of Chronic non-bacterial osteomyelitis (CNO) based on whole blood RNA sequencing (> 6Gb per sample)

2021-11-05 | GSE187429 | GEO

CNO stimulated hM3Dq-expressing iPS cell-derived neural cells

Project description:hM3Dq-expressing iPS cell-derived neural cells were stimulated by CNO treatment for two hours. Comparing to the vehicle-treated control, enhanced expressions of immediate early genes were observed.

2021-11-23 | GSE173243 | GEO

Whole-Blood gene expression profiling in primary Sjögren's Syndrome and healthy controls

Project description:Investigating differential gene expression between clinical phenotypes in primary Sjögren's Syndrome using matched healthy controls as a further comparator group. Samples are derived from the UK Primary Sjögren's Syndrome Registry (UKPSSR)

2019-09-30 | E-MTAB-8277 | biostudies-arrayexpress

Peripheral whole blood: Healthy control and Major depression disorder patients

Project description:Transcriptional profiling in the whole blood samples of healthy controls and major depression disorder (MDD) patients who have never been treated with depression medication. Samples included 20 healthy controls and 20 MDD patients who have never been treated with depression medication. Goal was to discover the differentially expressed genes.

2022-07-18 | GSE201332 | GEO

Expression in blood of schizophrenia patients and healthy controls

Project description:Expression in blood of schizophrenia patients and healthy controls

| PRJNA238013 | ENA

Blood based expression of colorectal cancer and healthy controls

Project description:Blood based expression of colorectal cancer and healthy controls

| PRJNA689481 | ENA

miRNA expression in blood of 15 schizophrenia patients and 15 healthy controls

Project description:The study profiles genome-wide miRNA expression in blood from 15 early-onset SZ (EOS) cases and 15 healthy controls. A total of 1070 miRNAs were detected by the microarrays in our samples. We profiles miRNA expression in 15 schizophrenia samples and 15 healthy controls to explore the alteration of miRNAs in schizophrenia.

2014-12-02 | GSE54578 | GEO

Gene expression analysis in whole blood samples obtained from donors diagnosed with MDD compared to healthy controls

Project description:This study investigated gene expression changes in whole blood samples obtained from donors diagnosed with major depressive disorder (MDD) compared to healthy controls. Micro-array data were available from whole blood on patients with MDD (N=128, 64 with generalised anxiety disorder, diagnosed by the MINI questionnaire, and 64 without anxiety disorder) and healthy controls (N=64). RNA was isolated from all samples using the standard PAXgene protocol on the Qiagen Biorobot 8000. All samples gave good quality RNA, as assessed by Agilent Bioanalyser. The yield range was 0.86-15.05ug with an average of 6.25ug. Samples were then randomised into batches, with each batch containing a representative number of controls, depression with anxiety and depression without anxiety, and the same ratio of females to males (3:1). 50ng of RNA from each sample was converted to a biotin labeled cDNA probe using NuGEN SPIA amplification. The probes were then hybridized to Affymetrix U133_Plus2.0 Genechips.

2017-05-12 | GSE98793 | GEO

Proteomic dataset on abnormal glucose tolerance versus healthy controls with 10 abnormal glucose tolerance. 10 in healthy controls

Project description:Proteomic dataset on abnormal glucose tolerance versus healthy controls with 10 abnormal glucose tolerance. 10 in healthy controls

2023-09-18 | PXD045432 |

Healthy Donor Controls for Immune Evaluation

Project description:Healthy Donor Controls for Immune Evaluation

| PRJNA1347104 | ENA